Over-expression of p45SKP2 in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27KIP1 down-regulation

Modern Pathology

Volumn 15, Issue 11, 2002, Pages 1227-1235

  Penin, R M ^a   Fernandez Figueras, M T ^a   Puig, L ^b   Rex, J ^a   Ferrandiz, C ^a   Ariza, A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cell cycle; Kaposi's sarcoma; Ki67; P27KIP1, p45SKP2, Proteasome, Ubiquitin

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; PROTEIN P27; PROTEIN SUBUNIT;

ARTICLE; CANCER GROWTH; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPOSI SARCOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

CELL CYCLE PROTEINS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIGASES; NEOPLASM STAGING; SARCOMA, KAPOSI; SEVERITY OF ILLNESS INDEX; SKIN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0036861277     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000036589.99516.D6     Document Type: Article

References (32)

1. Cordón-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications. Am J Pathol 1995;147:545-60.
2. Lisztwan J, Marti A, Sutterluty H, Gstaiger M, Wirbelauer C, Krek W. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45 (SKP2): Evidence for evolutionary conservation in the sub-unit composition of the CDC34-SCF pathway. EMBO J 1998; 17:368-83.
3. Harper JW. Protein destruction: Adapting roles for Cks proteins. Curr Biol 2001;11:431-5.
4. CIP/WAF1 and cyclin D proteins. Proc Natl Acad Sci USA 1998;95:11324-9.
5. Marti A, Wirbelauer C, Scheffner M, Krek W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1999;1:14-9.
6. Kip1. Biochem Biophys Res Commun 2001;282:853-60.
7. Schulman BA, Carrano AC, Jeffrey PD, Bowen Z, Kinnucan ER, Finnin MS, et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 2000;408:381-6.
8. Ganiatsas S, Dow R, Thompson A, Schulman B, Germain D. A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-ut. Oncogene 2001;20:3641-50.
9. Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 1998;152:585-90.
10. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998;153:681-7.
11. KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 1998;90:1284-91.
12. Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol 1999;187:200-6.
13. Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999;1:207-14.
14. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001;24:98:5043-8.
15. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, et al. Inverse relation between levels of p27 (Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 2001;91:1745-51.
16. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001;61:7044-7.
17. Yam CH, Ng RW, Siu WY, Lau AW, Poon RY. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2. Mol Cell Biol 1999;19:635-45.
18. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
19. Chor PJ, Santa Cruz DJ. Kaposi's sarcoma. A clinicopathologic review and differential diagnosis. J Cutan Pathol 1992; 19:6-20.
20. Kip1 in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement. J Pathol 2000;191:387-93.
21. Carrano AC, Eytan E, Hershko A, Pagano M. Skp2 is required for ubiquitin-mediated degradation of the Cdk inhibitor p27. Nat Cell Biol 1999;1:193-7.
22. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, et al. Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci 2001;98:2515-20.
23. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F, et al. The F-box protein Skp2 is a ubiquitylation target of a Cull-based core ubiquitin ligase complex: Evidence for a role of Cull in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 2000;19:5362-75.
24. Dow R, Hendley J, Pirkmaier A, Musgrove EA, Germain D. Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2. J Biol Chem 2001;276:45945-51.
25. O'Hagan RC, Ohh M, David G, de Alboran IM, Alt FW, Kaelin WG Jr, et al. Myc-enhanced expression of Cull promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev 2000;14:2185-91.
26. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM: A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001;413:323-7.
27. Morimoto M, Nishida T, Honda R, Yasuda H. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun 2000;270:1093-6.
28. Podust VN, Brownell JE, Gladysheva TB, Luo RS, Wang C, Coggins MB, et al. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci USA 2000;97:4579-84.
29. Duan H, Tsvetkov LM, Liu Y, Song Y, Swaroop M, Wen R, et al. Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation. Mol Carcinog 2001;30:37-46.
30. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, et al. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 1999;274:13886-93.
31. Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA, et al. Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J 1999; 18:644-53.
32. Kip1 levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J 1999;18:654-63.